-
Kirby McInerney LLP Announces Investigation of Shareholder Claims Against Regeneron Pharmaceuticals, Inc. (REGN)
18 Apr 2024 21:03 GMT
… investigating potential claims against Regeneron Pharmaceuticals, Inc. (“Regeneron” or the “Company … dollars in discounts provided to drug distributors. As a result, the … Regeneron’s Eylea drug was inflated above the amount allowed by Medicare. On …
-
REGENERON ALERT: Bragar Eagel & Squire, P.C. is Investigating Regeneron Pharmaceuticals, Inc. on Behalf of Regeneron Stockholders and Encourages Investors to Contact the Firm
18 Apr 2024 01:00 GMT
… investigating potential claims against Regeneron Pharmaceuticals, Inc. (“Regeneron” or the “Company … dollars in discounts given to drug distributors. These discounts were provided … 's Eylea drug was inflated above the amount allowed by Medicare. If …
-
DOJ Files Second Qui Tam Lawsuit Against Regeneron Pharmaceuticals
18 Apr 2024 00:54 GMT
… doctored sales reports to Medicare and Medicaid.
Regeneron is a pharmaceutical manufacturer that sells Eylea … claims, stating:
“The government alleges that Regeneron manipulated Medicare’s drug pricing … the costs of its drug to Medicare over many years and …
-
The Law Offices of Frank R. Cruz Announces Investigation of Regeneron Pharmaceuticals, Inc. (REGN) on Behalf of Investors
17 Apr 2024 18:33 GMT
… announces an investigation of Regeneron Pharmaceuticals, Inc. (“Regeneron” or the “ … the Company fraudulently inflated Medicare reimbursement rates for Eylea by knowingly submitting … to the Centers for Medicare and Medicaid Services that excluded certain …
-
Regeneron and Genentech battle for ophthalmologists’ affinity in Eylea HD, Vabysmo matchup
16 Apr 2024 20:26 GMT
After seven months on the market, Regeneron’s Eylea HD is already making strides with ophthalmologists.
According to Spherix Global Insights’ research, 81% of ophthalmologists who use Eylea HD to treat wet age-related macular …
-
DOJ sues Regeneron Pharmaceuticals over allegedly inflating Medicare reimbursements
16 Apr 2024 17:30 GMT
… York-based pharmaceutical company, over allegedly inflating Medicare reimbursement rates for Eylea, an … alleges that Regeneron manipulated Medicare';s drug pricing process, by knowingly … inflated the costs of its drug to Medicare over many years and …
-
Regeneron to defend against DOJ complaint on drug-price manipulation
16 Apr 2024 13:07 GMT
London: Regeneron Pharmaceuticals said on Monday … price of its macular degeneration drug Eylea.
"Reimbursing credit card … dollars to subsidize Eylea purchases by reimbursing drug distributors for … U.S. Food and Drug Administration for treating conditions …
-
Byooviz dosage
18 Apr 2024 20:05 GMT
… The Food and Drug Administration (FDA) has approved Byooviz … your doctor recommends repeating treatment.
Before treatment, your doctor will … to the dosage of Eylea?
In some ways. … doctor or another healthcare professional before taking any medication. The drug …
-
Regeneron to defend US Justice Department's complaint on drug-pricing manipulation
15 Apr 2024 23:44 GMT
… VIDEOS
(Reuters) - Regeneron Pharmaceuticals said on Monday the … for its macular degeneration drug Eylea is "meritless… Regeneron of manipulating Medicare';s drug-pricing process by … sales price for its Eylea drug.
(Reporting by Kanjyik Ghosh …
-
Regeneron Faces Lawsuit for Misreporting Eylea Prices to Medicare
15 Apr 2024 11:18 GMT
… Pharmaceuticals under the False Claims Act (FCA), accusing the biotechnology … Eylea (aflibercept) to the Centers for Medicare and Medicaid Services … that since Eylea's FDA approval in … quot;fundamental misunderstanding of drug price reporting standards,…